Drugs / Echinaforce Chewable tablets
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04999098 Comparator | Nov 2021 → May 2023 | COVID-19 | A. Vogel AG | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Echinaforce Chewable tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04999098 ↗ |
| Route | Oral | “Slowly sucking 1 x 3 Echinaforce Chewable tablets (total 3 tablets: 1'200mg EF) until dissolution” NCT04999098 ↗ |